In short. Three-dimensional planning involves three regulatory classes: planning software, printed guides or patient-specific implants, and patient-facing simulations. A clearance covers a named technical task, such as segmenting or measuring, and does not assert that an operation planned this way produces a better result.
Key points
- Three regulatory classes sit behind the single word approval.
- Planning software clearance covers defined technical tasks, not clinical outcomes.
- Guides and patient-specific implants are authorised separately from the software.
- A patient-facing simulation generally makes no regulated claim and carries no clearance.
- What falls into each class differs between jurisdictions.
Three regulatory classes behind one word
Three regulatory classes are involved in what is loosely called three-dimensional planning, and the word approval is used for all of them. Keeping them apart is the fastest way to know what any given clearance actually asserts.
What a software clearance covers
Software that segments a scan and generates a surgical plan is treated as a medical device in the jurisdictions that regulate it. Its clearance covers defined tasks: importing and displaying images, segmenting structures, measuring, and producing a plan that can be exported or used to manufacture something. Those are technical assertions about performance. They are not assertions that an operation planned this way produces a better result, and a clearance document does not claim that.
Guides and patient-specific implants are authorised separately
A guide manufactured from a plan is authorised separately, and a patient-specific implant is authorised as an individual device for an individual person. Both paths involve the manufacturer demonstrating that the object matches what was planned and can be produced to a standard. Neither path is a study of outcomes, and a patient-specific implant is authorised for the case it was made for rather than for a general indication.
Cleared for a task is not proven for an outcome
A regulator clears a tool to do something a tool can be tested on. Whether an operation produces a better result is an outcome question, and it is answered by clinical studies rather than by a device file. Confusing the two is the most common way a technical clearance gets presented as a clinical finding.
What is a patient-facing simulation regulated as?
A picture produced to illustrate a conversation is generally not a device at all, because it is not claiming to diagnose or treat. That is exactly why it should be described carefully: it carries no clearance because it makes no regulated claim, and the absence of a claim is not the same as the presence of evidence. Where a clinic shows a rendered image beside a cleared system as though one approval covered both, an approval is being borrowed.
Why does the same product fall into different classes in different markets?
The classes exist in most regulated markets, but what falls into each one differs. A planning system available in one market may have no equivalent authorisation in another, a guide may be regulated as a custom-made device in one place and as a standard device in another, and the state of regulation changes more often than the underlying evidence does.
How the three classes differ
| What is regulated | What it is | What the clearance asserts | What it does not assert |
|---|---|---|---|
| Planning software | Software that segments a scan and generates a plan | Defined tasks such as importing, displaying, segmenting and measuring | That an operation planned this way produces a better result |
| A printed guide | A guide manufactured from a plan | That the object matches the plan and can be produced to a standard | Outcomes |
| A patient-specific implant | An individual device for an individual person | That it matches the plan and the production standard | A general indication or an outcome |
| A patient-facing simulation | A picture produced to illustrate a conversation | No regulated claim | That it diagnoses or treats, and no evidence follows from that absence |
| A clearance document | A technical file about performance | A named task the tool can be tested on | A clinical finding |
| A national class | The local regulatory category | What falls into the class in that market | The same class in another market or the underlying evidence |
What should you ask about a clearance?
Three questions are worth asking. Which of the three is cleared: the software, the guide, or neither? What named task does the clearance cover, and does the claim being made to you go beyond it? Is the thing you are being shown a regulated device at all, or an illustration with no claim attached?
What precise vocabulary changes
None of this makes the technology suspect. It makes the vocabulary precise, which is the only way to read a claim about it.
Sources
- U.S. Food and Drug Administration (FDA): regulatory information on medical device software and patient-specific implants
- European Medicines Agency (EMA) and national competent authorities: medical device regulation and custom-made device guidance
- National Medical Products Administration (NMPA, China): approved medical devices and their indications
Internal links
Frequently asked questions
Is planning software regulated as a medical device?
In the markets that regulate it, yes. It is cleared or approved for defined technical tasks such as segmentation, measurement and generating a surgical plan. The clearance names those tasks, and it does not assert that an operation performed with the plan produces a better result.
Is a printed guide covered by the software's approval?
No. A guide is a separate device, authorised on its own, usually for a named procedure or anatomical site. That is why a guide has its own failure modes and its own labelling, and why an approval of the planning software says nothing about the guide manufactured from its output.
Does a cleared device mean the operation is proven?
No. A clearance is evidence that a manufacturer has shown a defined technical performance to a regulator's standard. It is not evidence about outcomes, and every regulator that clears this kind of software is clearing a tool rather than a treatment.
Risks & Limitations
- A rendered simulation is an illustration of a plan, not a prediction of how a face will look.
- A plan built on a poor scan, or on a boundary traced wrongly, is a precise plan of the wrong shape.
- Planning software, printed guides and patient-facing images sit in three regulatory classes, and one approval is not another.
- No study has shown that planning lowers the overall complication rate.
- A scan records structure in one posture, and does not replace an examination of how tissue behaves.
When to Seek Care
- A wound that is opening, or spreading redness, warmth or discharge — contact the service that holds your records.
- Fever, or pain that is worsening rather than settling after an operation.
- Bleeding that does not stop with gentle pressure.
- If you were shown a simulation and are unsure what it represented, ask the team that showed it to you, and ask to see the plan behind it.
References & Further Reading
- U.S. Food and Drug Administration (FDA) — cleared and approved surgical planning software, guides and patient-specific implants
- European Medicines Agency (EMA) and national competent authorities — medical device regulation and custom-made device guidance
- National Medical Products Administration (NMPA, China) — approved medical devices and their indications
- National Institute for Health and Care Excellence (NICE, UK) — guidance on imaging and surgical planning
- Cochrane Library — systematic reviews of computer-assisted surgery
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.